FIELD: medicine, molecular biology. SUBSTANCE: invention describes endothelial cells expressing protein with I&B-activity that results to complete repression of NF&B- -dependent activation of these cells. Cells can be obtained by change of genotype of indicated cells, for example, by insertion of heterologous sequences encoding I&B-activity or promoter. Promoter provides constructive expression of I&B- -activity being directly after effects by stimuli activating endothelial cells or if necessary as the response to the exogenous predetermined stimulus. Invention provides making transplanting material useful for transplantation, for example, for xenotransplantation since they are characterized by the favorable and less rejection probability. EFFECT: improved properties of transplanting material. 16 cl, 5 ex
Title |
Year |
Author |
Number |
VASCULAR ADHESION PROTEIN-1 OF AMINOOXIDASE ACTIVITY |
1998 |
- Jalkanen Sirpa
- Salmi Marko
- Smit Dehjvid Dzhon
- Bono Petri
|
RU2204838C2 |
RECOMBINANT DNA ELEMENTS FOR RECOMBINANT PROTEINS EXPRESSION IN THE HOST CELL |
2012 |
- Gomes Sebastyan Silviya
- Lopes Vidal Khaver
- Martines Eskribano Khose Ankhel
|
RU2619161C2 |
ALK1 ANTAGONISTS AND THEIR APPLICATION IN THE TREATMENT OF KIDNEY-CELLULAR CARCINOMA |
2013 |
- Bkhatt Rupal S.
- Kumar Ravindra
- Majer Dzhejms V.
- Pirsoll Robert
- Sherman Mettyu
- Solban Nikolas
|
RU2633638C2 |
METHOD FOR MODIFYING DNA FRAGMENT ENCODING INSECTICIDE PROTEIN BACILLUS THURINGIENSIS, DNA FRAGMENT CONTAINING STRUCTURAL GENE ENCODING INSECTICIDE PROTEIN AND DNA FRAGMENT CONTAINING STRUCTURAL GENE ENCODING FUSED PROTEIN |
1990 |
- Dehvid Ehllen Fishoff[Us]
- Frederik Dzhosef Perlak[Us]
|
RU2107725C1 |
MODULATION OF IL-5 AND IL-MEDIATED CELL RESPONSES |
2001 |
- Li Sjan' Chan
- Strom Terri
- Chzhehn Sin' Sjao
|
RU2280255C2 |
COMPOSITIONS AND METHOD FOR IMMUNOSUPPRESSION |
2001 |
- Strom Terri B.
- Maslinski Vlodzimezh
- Zkheng Ksin Ksiao
- Kim Jon Su
- Lakra Sil'Vi Ferrari
|
RU2270691C2 |
ISOLATED DNA SEQUENCE, VECTOR, METHOD OF PREPARING HOMOGENEOUS PROTEIN GP 350, HOMOGENEOUS PROTEIN GP 350, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF EBV-MEDIATED DISEASE OR STATE |
1995 |
- Spaet Richard
- Dzhekmehn Vintrop T.
|
RU2178807C2 |
POLYPEPTIDES DERIVED FROM TRYPTOPHANYL-TRNA-SYNTHETASE AND USES THEREOF IN CONTROLLING OF VASCULARISATION |
2002 |
- Shimmel' Pol
- Vakasugi Kejsuke
- Frehdlehnder Martin
|
RU2297425C2 |
MUTANTS OF ACTIVATION INDUCED CYTIDINE DEAMINASE (AID) AND METHODS OF APPLYING THEREOF |
2010 |
- Van Men
- Jang Zizkhen
- Rada Kristina
- Nojberger Majkl
|
RU2537264C2 |
NEW PROTEINS SHOWING INHIBITORY ACTIVITY RELATIVELY TO INSECTS |
2016 |
- Bowen, David, J.
- Chay, Catherine, A.
- Flasinski, Stanislaw
- Yin, Yong
|
RU2765310C2 |